• Contact

  • Newsletter

  • About us

  • Delivery options

  • Prospero Book Market Podcast

  • Essential Guide to Neurodegenerative Disorders: Mechanistic, Diagnostic and Therapeutic Advances

    Essential Guide to Neurodegenerative Disorders by Mohamed, Wael;

    Mechanistic, Diagnostic and Therapeutic Advances

      • GET 20% OFF

      • The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
      • Publisher's listprice EUR 232.99
      • The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.

        96 632 Ft (92 031 Ft + 5% VAT)
      • Discount 20% (cc. 19 326 Ft off)
      • Discounted price 77 306 Ft (73 625 Ft + 5% VAT)

    96 632 Ft

    db

    Availability

    printed on demand

    Why don't you give exact delivery time?

    Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.

    Product details:

    • Publisher Elsevier Science
    • Date of Publication 28 November 2024

    • ISBN 9780443157028
    • Binding Paperback
    • No. of pages700 pages
    • Size 234x190 mm
    • Weight 1880 g
    • Language English
    • 616

    Categories

    Long description:

    Handbook of Neurodegenerative Disorders: Mechanism, Diagnostic and Therapeutic Advances provides a comprehensive review on the current biomedical studies aimed at identifying the underlying causes of neurodegeneration. This book reviews the most recent developments in molecular and cellular processes altered during neurodegeneration. Divided into four parts, the first covers the mechanism of cell death in neurodegeneration. The second section reviews the recent progress in gene and gene products in neurodegeneration, including Huntington's disease, Parkinson's disease, Friedreich' s ataxia, and spinal muscular atrophy. The final sections cover the current and future diagnostic techniques of neurodegenerative disorders along with therapeutic approaches.

    More

    Table of Contents:

    Part-I: Mechanism of cell death in neurodegeneration
    1. Pathways in AD
    2. Shared signalling pathways in Alzheimer’s and metabolic disease
    3. Abeta pathology in AD and its potential to seed and propagate
    4. Single-cell approaches to identify shared and distinct signatures across neurodegenerative diseases
    5. Modelling of neurodegenerative disease using brain organoids
    6. The structural basis of protein assembly into amyloid filaments in neurodegenerative disease-Benjamin
    7. Blood brain barrier in neurodegenerative disorders
    8. Protein misfolding in neurodegeneration
    9. Neuroinflammation and neurodegeneration
    10. Gut-Brain Axis in neurodegeneration
    11. Modelling Neural Circuits in Parkinson’s Disease
    12. Neuropathology of Parkinsonism in Alzheimer’s Disease
    13. Huntington Disease updates
    14. Neuroinflammation in neurodegeneration

    Part-II: Gene and gene products in neurodegeneration
    15. Big data and neurodegeneration disorders
    16. Genomics and PD
    17. RNA Binding Proteins and the Genesis of Neurodegenerative Diseases-Ahmed Moustafa, Egypt
    18. Molecular Genetics of Huntington’s Disease
    19. neuronopathic LSDs: opportunities and challenges
    20. Nutrigenomics and PD
    21. Genes and MS: updates
    22. Genetic mapping and big data in ALS

    Part-III: Present and future diagnostic approaches of neurodegenerative disorders
    23. Biomarkers in AD
    24. Biomarkers of PD
    25. HMGB complex in PD diagnosis
    26. Psychological assessment of PD patients

    Part-IV: Present and future therapeutics of neurodegenerative disorders
    27. Pharmacotherapy of neurodegenerative disorders: challenges and hopes
    28. Advanced Drug Delivery Nanosystems: Perspectives and Regulatory Issues
    29. Towards the Development of a Device to Improve the Gait of Patients Suffering from Parkinson’s Disease
    30. Developing Antisense Therapies for Neurodegenerative Diseases
    31. Advances in Gene Therapies for the CNS
    32. Nutrition and PD
    33. Stem cell therapy in NDG disorders

    More